IV ketamine for chronic daily headaches
Treatments studied
Part of Brain & nervous system, Pain clinical trials.
This trial tests whether an IV dose of ketamine can reduce chronic daily headaches and is safe for people with this condition. It may help by lowering headache frequency and severity, but it also has several medicine and health-related safety checks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 75 years old
- You have chronic daily headaches for at least 3 months (headaches on 15+ days per month, lasting 4+ hours)
- Your recent blood tests show your liver and kidneys are working normally
- You are not pregnant or breastfeeding
- You are not taking certain headache-related medicines recently (CGRP blockers in 1 month or Botox in 3 months)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a combination of ketamine and talk therapy can help people with depression that hasn't responded to other treatments. You will receive ketamine in a safe, supervised setting while working with a therapist.
This trial tests if a combination of ketamine and lidocaine given through an IV can help people with constant, hard-to-treat migraines. It aims to find a new relief option for those who haven't improved with other treatments.
This trial tests if ketamine can help people with long-term health issues. It aims to find new treatments for chronic conditions that haven't responded well to other therapies.
This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.
This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.
This Phase 1/2 study tests hydroxynorketamine (a related ketamine-type medicine) to see if it can reduce chronic nerve pain in the arms or legs. You may be able to join if you have nerve pain for more than 3 months and meet safety and health check requirements.
Hear when a new Chronic Daily Headache trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.